Decreased Circulating MANF in Women with PCOS is Elevated by
Metformin Therapy and is Inversely Correlated with Insulin Resistance and
Hyperandrogenism
1
Department of Endocrinology and Metabolism, The Second Affiliated
Hospital of Chongqing Medical University, Chongqing, China
,
Gangyi Yang
1
Department of Endocrinology and Metabolism, The Second Affiliated
Hospital of Chongqing Medical University, Chongqing, China
,
Yanjun Jia
2
Laboratory of Endocrinology, The Second Affiliated Hospital of
Chongqing Medical University, Chongqing, China
,
Yang Li
1
Department of Endocrinology and Metabolism, The Second Affiliated
Hospital of Chongqing Medical University, Chongqing, China
,
Wenzhen Deng
1
Department of Endocrinology and Metabolism, The Second Affiliated
Hospital of Chongqing Medical University, Chongqing, China
,
Min Long
1
Department of Endocrinology and Metabolism, The Second Affiliated
Hospital of Chongqing Medical University, Chongqing, China
,
Chengpan Wang
1
Department of Endocrinology and Metabolism, The Second Affiliated
Hospital of Chongqing Medical University, Chongqing, China
,
Dongfang Liu
1
Department of Endocrinology and Metabolism, The Second Affiliated
Hospital of Chongqing Medical University, Chongqing, China
3
Chongqing Clinical Research Center for Geriatrics and Gerontology, The
Second Affiliated Hospital of Chongqing Medical University, Chongqing,
China
› Author AffiliationsFunding Information Medical Scientific Research Project of Chongqing Health Planning
Committee; Grant Nos: 2016MSXM030 and 2016ZDXM011. National
Natural Science Foundation of China; Grant Nos: 81370467
and 81501199. Natural Science Foundation Project of Chongqing
cstc; Grant Nos: cstc2017jcyjAX0016 and cstc2017shmsA130069.
Mesencephalic astrocyte-derived neurotrophic factor (MANF) is a novel
neurotrophic factor. Although recent studies have suggested that MANF
appeared to be associated with insulin resistance, the results have been
inconsistent. The aim of our study was to determine the serum MANF levels in
women with PCOS and controls, to investigate their relationship to insulin
resistance, and to evaluate circulating MANF changes with metformin
intervention in PCOS women. We conducted a series of cross-sectional and
interventional studies in 90 newly diagnosed patients with PCOS and 60 age-
and gender-matched controls. Oral glucose tolerance test and
euglycemic-hyperinsulinemic clamps were performed to assess the glucose
tolerance and insulin sensitivity. Forty-three women with PCOS were randomly
assigned to six months of oral metformin therapy. Serum MANF levels were
significantly lower in women with PCOS than in controls. Serum MANF levels
were positively correlated with M-value and negatively correlated with body
mass index (BMI), body fat percentage (FAT), homeostatic model assessment of
insulin resistance (HOMA-IR), and free androgen index (FAI). Multivariate
stepwise regression demonstrated that serum MANF levels were independently
associated with M-value and FAI. After six months of metformin treatment,
there was a significant increase in serum MANF levels in PCOS women. Serum
MANF levels are decreased in women with PCOS, and are reversely related to
insulin resistance and hyperandrogenism. Metformin treatment elevates serum
MANF levels and alleviates insulin resistance and hyperandrogenism in PCOS
women.
1
March WA,
Moore VM,
Willson KJ.
et al. The prevalence of polycystic ovary syndrome in a community sample assessed under
contrasting diagnostic criteria. Hum Reprod 2010; 25: 544-551
2 Rotterdam EA-SPcwg Revised 2003 consensus on diagnostic criteria and long-term health risks related
to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47
3
Diamanti-Kandarakis E,
Dunaif A.
Insulin resistance and the polycystic ovary syndrome revisited: An update on
mechanisms and implications. Endocr Rev 2012; 33: 981-1030
4
Kocer D,
Bayram F,
Diri H.
The effects of metformin on endothelial dysfunction, lipid metabolism and
oxidative stress in women with polycystic ovary syndrome. Gynecol Endocrinol 2014; 30: 367-371
6
Petrova P,
Raibekas A,
Pevsner J.
et al. MANF: A new mesencephalic, astrocyte-derived neurotrophic factor with
selectivity for dopaminergic neurons. J Mol Neurosci 2003; 20: 173-188
7
Lindholm P,
Peranen J,
Andressoo JO.
et al. MANF is widely expressed in mammalian tissues and differently regulated after
ischemic and epileptic insults in rodent brain. Mol Cell Neurosci 2008; 39: 356-371
8
Lindahl M,
Saarma M,
Lindholm P.
Unconventional neurotrophic factors CDNF and MANF: Structure, physiological
functions and therapeutic potential. Neurobiol Dis 2017; 97: 90-102
10
Sousa-Victor P,
Neves J,
Cedron-Craft W.
et al. MANF regulates metabolic and immune homeostasis in ageing and protects against
liver damage. Nature Metabol 2019; 1: 276-290
11
Wu T,
Zhang F,
Yang Q.
et al. Circulating mesencephalic astrocyte-derived neurotrophic factor is increased in
newly diagnosed prediabetic and diabetic patients, and is associated with
insulin resistance. Endocr J 2017; 64: 403-410
14 American Diabetes Association Classification and diagnosis of diabetes. Sec. 2. In Standards of medical care
in diabetes – 2019. Diabetes Care 42: 13-28
15
DeFronzo RA,
Tobin JD,
Andres R.
Glucose clamp technique: a method for quantifying insulin secretion and
resistance. Am J Physiol 1979; 237: E214-E223
16
Zhao W,
Yuan T,
Sun Q.
et al. Establishment of hyperinsulinemic euglycemic clamp technique and the reference
value of insulin sensitivity index in Chinese. Chin J Clin Nutri. 2009; 17: 17-20
19
Apostolou A,
Shen Y,
Liang Y.
et al. Armet, a UPR-upregulated protein, inhibits cell proliferation and ER
stress-induced cell death. Exp Cell Res 2008; 314: 2454-2467
20
Cunha DA,
Cito M,
Grieco FA.
et al. Pancreatic beta-cell protection from inflammatory stress by the endoplasmic
reticulum proteins thrombospondin 1 and mesencephalic astrocyte-derived
neutrotrophic factor (MANF). J Biol Chem 2017; 292: 14977-14988
21
Dooley J,
Tian L,
Schonefeldt S.
et al. Genetic predisposition for beta cell fragility underlies type 1 and type 2
diabetes. Nat Genet 2016; 48: 519-527
22
Galli E,
Harkonen T,
Sainio MT.
et al. Increased circulating concentrations of mesencephalic astrocyte-derived
neurotrophic factor in children with type 1 diabetes. Sci Rep 2016; 6: 29058
23
Danilova T,
Belevich I,
Li H.
et al. MANF is required for the postnatal expansion and maintenance of pancreatic
beta-cell mass in mice. Diabetes 2019; 68: 66-80
25
Yavarna T,
Al-Dewik N,
Al-Mureikhi M.
et al. High diagnostic yield of clinical exome sequencing in Middle Eastern patients
with Mendelian disorders. Hum Genet 2015; 134: 967-980
26
Cen J,
Sargsyan E,
Forslund A.
et al. Mechanisms of beneficial effects of metformin on fatty acid-treated human
islets. J Mol Endocrinol 2018; 61: 91-99